The latest update is out from Avadel Pharmaceuticals ( ($AVDL) ). On June 22, 2023, Jazz Pharmaceuticals filed a lawsuit against the FDA and...
1 day ago

The good news for shareholders is that Avadel Pharmaceuticals has dazzling revenue growth, so there's a very good chance it can boost its free...
2 weeks ago

The following is a letter that ASL Strategic Value Fund sent to the Board of Directors of Avadel Pharmaceuticals (NASDAQ:AVDL):
4 months ago

The consensus price target hints at an 81.6% upside potential for Avadel (AVDL). While empirical research shows that this sought-after...
2 weeks ago

The Federal Circuit ruled that the injunction unlawfully covered conduct protected by the Hatch-Waxman Act's “safe harbor” provision, 35 U.S.C....
1 month ago

DUBLIN, June 16, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to...
2 weeks ago

Avadel Pharmaceuticals lost 51 cents a share on just over $169 million of revenues in FY2024. The current analyst firm consensus sees Avadel...
1 month ago

Avadel Announces US Launch of Lumryz for Narcolepsy ... Avadel Pharmaceuticals plc announced that Lumryz—an extended-release formulation of sodium...
1 month ago

Avadel is a biopharmaceutical company focused on transforming medicines to transform lives. We are disrupting treatment paradigms where it's needed most –...
2 months ago

by Dennis Crouch. The Federal Circuit's May 6, 2025 decision in Jazz Pharmaceuticals v. Avadel focuses on the scope of injunctive relief for...
1 month ago